Private company
Saturn V Capital Management LP
Limited partnership registered in the United States, active since 2021. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersAustin, United States2
- Legal formLimited Partnership2
- Kind of organizationLimited partnership2
- LEI254900S5UTVYRQGJSH842
- StatusActive2
- LEI statusIssued and current2
- Registered addressC/O VCORP SERVICES, LLC, 19801 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 55048712
Corporate structure
Saturn V Capital Management LP sits at the top of its group. 6 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Saturn V Capital Management LP
- Xiaoying (nmn) Tian Owns 75% or more of Saturn V Capital Management LP, since 09/2023 (Form ADV)
- Saturn V Capital Management LP Austin, Texas, United States
- Immix Biopharma, Inc. Stake · Los Angeles, California
- KalVista Pharmaceuticals, Inc. Stake · Cambridge, Massachusetts, United States
- Monopar Therapeutics Stake · Northbrook, Illinois, United States
- X4 Pharmaceuticals, Inc Stake · Cambridge, Massachusetts, United States
- SATURN V CAPITAL LP Fund · Austin, Texas, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (4 companies); owners and owned firms from Form ADV, the registration investment advisers file with the SEC. Each entity in the chart links to its source.
Investment adviser
Saturn V Capital Management LP is registered with the SEC as an investment adviser. This is what it reports on Form ADV, the registration every adviser files and keeps current.
- Assets it manages$793.2M3 4 accounts, all with discretion
- Employees6 4 in investment advice or research
- ClientsPooled investment vehicles (other than investment companies and: 4 ($793.2M)
- How it is paidA percentage of assets under its management; Performance-based fees
- What it doesPortfolio management for pooled investment vehicles (other than investment companies)
- Holds client assetsYes: cash and securities
- RegistrationSEC 801-128448, CRD 316649 IAPD record
Who owns it
Owners of 5% or more as the firm lists them (Schedule A), and the owners of those owners up the chain (Schedule B).
- Xiaoying (Nmn) Tianowns 75% or more, since 09/2023
- Xiaoying (Nmn) Tianowns 75% or more of SVCM GP LLC, since 09/2023
Timeline
- Mar 15, 2021Founded Saturn V Capital Management LP is founded2
Filings
18 filings to the SEC since October 2021: 18 other. The latest 18:
- Aug 28, 2026N-PX EDGAR
- Aug 14, 202613F-HR EDGAR
- May 15, 202613F-HR EDGAR
- Feb 17, 202613F-HR EDGAR
- Nov 14, 202513F-HR EDGAR
- Aug 29, 2025N-PX EDGAR
- Aug 13, 202513F-HR EDGAR
- May 15, 202513F-HR EDGAR
- Feb 14, 202513F-HR EDGAR
- Nov 14, 202413F-HR EDGAR
- Aug 30, 2024N-PX EDGAR
- Aug 14, 202413F-HR EDGAR
- May 15, 202413F-HR EDGAR
- Feb 14, 202413F-HR EDGAR
- Nov 14, 202313F-HR EDGAR
- Aug 14, 202313F-HR EDGAR
- May 15, 202313F-HR EDGAR
- Feb 9, 202313F-HR EDGAR
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Stakes it holds
Saturn V Capital Management LP has told the SEC it owns more than 5% of 4 companies, latest first (Schedules 13D and 13G).
- Monopar TherapeuticsSCHEDULE 13G/A May 15, 2026 to Aug 12, 20264
- Immix Biopharma, Inc.SCHEDULE 13G Feb 17, 20265
- X4 Pharmaceuticals, IncSCHEDULE 13G Feb 17, 20266
- KalVista Pharmaceuticals, Inc.SC 13G Feb 12, 20247
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7